Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9747 |
High Similarity |
NPD7054 |
Approved |
0.9686 |
High Similarity |
NPD7472 |
Approved |
0.9563 |
High Similarity |
NPD7074 |
Phase 3 |
0.9506 |
High Similarity |
NPD7808 |
Phase 3 |
0.9503 |
High Similarity |
NPD6797 |
Phase 2 |
0.9444 |
High Similarity |
NPD7251 |
Discontinued |
0.9437 |
High Similarity |
NPD3818 |
Discontinued |
0.9423 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.9387 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.9167 |
High Similarity |
NPD1934 |
Approved |
0.9074 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.9074 |
High Similarity |
NPD6166 |
Phase 2 |
0.9074 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.9024 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8987 |
High Similarity |
NPD2801 |
Approved |
0.8987 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8931 |
High Similarity |
NPD3817 |
Phase 2 |
0.8797 |
High Similarity |
NPD4380 |
Phase 2 |
0.8774 |
High Similarity |
NPD1511 |
Approved |
0.8662 |
High Similarity |
NPD1512 |
Approved |
0.8642 |
High Similarity |
NPD3882 |
Suspended |
0.8642 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8639 |
High Similarity |
NPD6559 |
Discontinued |
0.8476 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8387 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8387 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8373 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8365 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8354 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8344 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8333 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8323 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8293 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8261 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8256 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8246 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8242 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8205 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8187 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8182 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8171 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8166 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8148 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.8141 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8137 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8137 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8129 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8107 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8107 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.8103 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.8072 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7977 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7977 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7953 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.791 |
Intermediate Similarity |
NPD8312 |
Approved |
0.791 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7907 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7904 |
Intermediate Similarity |
NPD37 |
Approved |
0.7892 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7888 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7885 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7885 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7885 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7882 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7875 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.787 |
Intermediate Similarity |
NPD4965 |
Approved |
0.787 |
Intermediate Similarity |
NPD4966 |
Approved |
0.787 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7861 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7853 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7834 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7831 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7812 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.779 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7785 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7778 |
Intermediate Similarity |
NPD919 |
Approved |
0.7778 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7722 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7701 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7701 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7701 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7701 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7701 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7701 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7701 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7701 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7692 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7688 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7669 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7661 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7658 |
Intermediate Similarity |
NPD943 |
Approved |
0.7656 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7647 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7643 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.764 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7628 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7616 |
Intermediate Similarity |
NPD3749 |
Approved |
0.761 |
Intermediate Similarity |
NPD447 |
Suspended |
0.761 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7598 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7579 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7564 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7531 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7515 |
Intermediate Similarity |
NPD6190 |
Approved |
0.75 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7487 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7487 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7487 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7487 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7487 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7485 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7485 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7485 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7469 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7448 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7448 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7447 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7435 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7433 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7433 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7423 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7423 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7421 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7403 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7396 |
Intermediate Similarity |
NPD920 |
Approved |
0.7394 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7394 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7381 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7371 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7363 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7362 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7348 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7347 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7347 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.734 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.734 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7317 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7317 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7316 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7316 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.731 |
Intermediate Similarity |
NPD7801 |
Approved |
0.731 |
Intermediate Similarity |
NPD3226 |
Approved |
0.731 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7296 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7296 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7289 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7289 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7283 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7278 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7262 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7256 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7239 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7238 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7233 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7219 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7215 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7205 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7205 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7204 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7204 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.72 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7197 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7196 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7196 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7196 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7188 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7179 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7179 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7179 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7178 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7178 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7178 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7169 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7169 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7167 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7143 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7128 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7111 |
Intermediate Similarity |
NPD5242 |
Approved |
0.711 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7099 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7095 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7077 |
Intermediate Similarity |
NPD5005 |
Approved |
0.7077 |
Intermediate Similarity |
NPD5006 |
Approved |
0.7074 |
Intermediate Similarity |
NPD6841 |
Approved |
0.7074 |
Intermediate Similarity |
NPD6843 |
Phase 3 |
0.7074 |
Intermediate Similarity |
NPD6842 |
Approved |
0.707 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.707 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7056 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7056 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7055 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7048 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7044 |
Intermediate Similarity |
NPD3225 |
Approved |
0.703 |
Intermediate Similarity |
NPD7930 |
Approved |
0.7029
|
Intermediate Similarity |
NPD6386 |
Approved |